DR. DANIEL JOHN BARUFFI O.D.
Prescription History 1982916458
Optometrist in Wilmington, DE
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. DANIEL JOHN BARUFFI O.D., an active Optometrist specialist practicing in Wilmington, DE. Our medical registry currently tracks 6 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 376 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 210 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other DE PrescribersVs. DE Avg |
|---|---|---|---|
| Latanoprost | 210 | $23.49 | ▲ More than typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2023, this provider wrote 210 Medicare prescriptions for Latanoprost, about 1.6 times the volume of the typical Delaware prescriber of this medication (130). Medicare paid an average of $23.49 per fill, versus $22.14 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 513.8 30-Day Fills standardized to 30-day supplies 15,329 Days of Medication total across all patients in 2023 | |||
| Timolol Maleate | 68 | $50.26 | ≈ Typical |
About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. In 2023, this provider wrote 68 Medicare prescriptions for Timolol Maleate, about the same volume as the typical Delaware prescriber of this medication (64). Medicare paid an average of $50.26 per fill, versus $26.75 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 191.9 30-Day Fills standardized to 30-day supplies 5,746 Days of Medication total across all patients in 2023 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 36 | $21.38▼ below DE avg | ▼ Less than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 36 Medicare prescriptions for Dorzolamide-Timolol, about half the volume of the typical Delaware prescriber of this medication (71). Medicare paid an average of $21.38 per fill, versus $29.24 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DE average for this medication. 85.9 30-Day Fills standardized to 30-day supplies 2,575 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate | 34 | $41.11▼ below DE avg | ▼ Less than typical |
About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 34 Medicare prescriptions for Brimonidine Tartrate, about 61% of the volume of the typical Delaware prescriber of this medication (56). Medicare paid an average of $41.11 per fill, versus $70.53 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DE average for this medication. 69.2 30-Day Fills standardized to 30-day supplies 2,075 Days of Medication total across all patients in 2023 | |||
| Travoprost | 17 | $470.88 | ▼ Less than typical |
About Travoprost: Travoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol derivative that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 17 Medicare prescriptions for Travoprost, about 68% of the volume of the typical Delaware prescriber of this medication (25). Medicare paid an average of $470.88 per fill, versus $276.88 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 40.5 30-Day Fills standardized to 30-day supplies 1,210 Days of Medication total across all patients in 2023 | |||
| Minocycline Hcl | 11 | $49.65 | ▼ Less than typical |
About Minocycline Hcl: This medication is used to treat acne or rosacea. Show more ▾ Minocycline belongs to a class of drugs known as tetracycline antibiotics. However, it is not used to treat skin infections. It helps decrease pimples and red bumps that happen with acne or rosacea. A TETRACYCLINE analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant STAPHYLOCOCCUS infections. In 2023, this provider wrote 11 Medicare prescriptions for Minocycline Hcl, about a third of the volume of the typical Delaware prescriber of this medication (35). Medicare paid an average of $49.65 per fill, versus $28.92 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 23.5 30-Day Fills standardized to 30-day supplies 675 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. DANIEL JOHN BARUFFI O.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Optometrist prescribing approach at this Wilmington, DE practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among DE prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
